C.M. Bidwell & Associates’s AngioDynamics ANGO Stock Holding History

C.M. Bidwell & Associates’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-10,220	Closed	-$282K	–	531
2021 Q4	$282K	Hold	10,220	–	–	0.17%	106
2021 Q3	$265K	Hold	10,220	–	–	0.18%	105
2021 Q2	$277K	Sell	10,220 -265	-3%	-$6.47K	0.18%	103
2021 Q1	$245K	Hold	10,485	–	–	0.18%	97
2020 Q4	$161K	Buy	+10,485	New	+$133K	0.13%	153
2017 Q2	–	Sell	-12,100	Closed	-$210K	–	324
2017 Q1	$210K	Buy	12,100 +950	+9%	+$15.9K	0.05%	149
2016 Q4	$188K	Buy	11,150 +3,645	+49%	+$60.8K	0.04%	169
2016 Q3	$132K	Sell	7,505 -50	-0.7%	-$811	0.03%	203
2016 Q2	$109K	Buy	+7,555	New	+$94.4K	0.03%	190

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

C.M. Bidwell & Associates's ANGO Position: Q1 2022 in Review

C.M. Bidwell & Associates sold out of AngioDynamics (ANGO) in Q1 2022, closing a stake of 10,220 shares — an estimated $282K sold.

C.M. Bidwell & Associates first reported a position in ANGO in Q2 2016 and held it in 9 quarters. The position peaked at $282K in Q4 2021. 144 funds tracked by Wall St. Rank hold ANGO as of Q1 2022.

C.M. Bidwell & Associates reported no remaining AngioDynamics position as of Q1 2022 after selling out during the quarter.
C.M. Bidwell & Associates sold 10,220 AngioDynamics shares in Q1 2022, an estimated $282K.
C.M. Bidwell & Associates first reported a position in AngioDynamics in Q2 2016 and held it in 9 quarters.
C.M. Bidwell & Associates's AngioDynamics position peaked at $282K in Q4 2021.
144 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2022.

Based on C.M. Bidwell & Associates's 13F filing for Q1 2022, filed 29 Apr 2022.